Urgent Directives from Local Authorities Following the national mandate from the Drug Administration of Vietnam, the Ho Chi Minh City Department of Health has issued an urgent directive instructing all healthcare institutions and pharmaceutical businesses within the city to immediately cease the distribution and use of a specific batch of Sodium Chloride 0.9% eye drops manufactured by Pharmedic Pharmaceutical Pharmaceutical Joint Stock Company.
-
Batch Details: Registration number 893100060724, batch number 10370725, manufactured on July 14, 2025, with an expiration date of January 14, 2028.
-
Reason for Action: The product failed to meet regulatory requirements for the “clarity” index, classified as a Level 3 quality violation.
Local ward and commune authorities have been tasked with monitoring compliance across pharmacies and private clinics, ensuring strict enforcement of the recall.
Consumer Rights, Refunds, and Compensation Protocols Officials from the Drug Administration of Vietnam outlined framework conditions to safeguard consumers and distributors:
-
Return Policy: Customers and retail pharmacies are entitled to return the affected eye drops to their point of purchase for a full refund or a product replacement.
-
Financial Accountability: Pharmedic is legally obligated to cover all operational expenses connected to the logistics, recovery, and final destruction of the defective batch. Consumers and healthcare venues bear no financial liability.
-
Damage Liability: In the event that a consumer experiences documented adverse health effects from using the recalled batch, they maintain the legal right to claim financial compensation for medical treatment expenses under civil law regulations. Citizens facing difficulties during the product return or compensation process may report the issues to local departments of health for administrative support.
Source: https://tuoitre.vn/tp-hcm-phat-thong-bao-khan-ve-lo-thuoc-nho-mat-bi-thu-hoi-20260516110056639.htm